Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 38% ± 21% | |
peripheral blood | 11 studies | 19% ± 4% | |
lung | 11 studies | 26% ± 10% | |
eye | 6 studies | 41% ± 20% | |
liver | 5 studies | 35% ± 20% | |
heart | 4 studies | 24% ± 4% | |
kidney | 4 studies | 20% ± 3% | |
adipose | 4 studies | 34% ± 16% | |
pancreas | 3 studies | 44% ± 22% | |
bone marrow | 3 studies | 26% ± 12% | |
placenta | 3 studies | 37% ± 15% | |
intestine | 3 studies | 25% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 12507.99 | 180 / 180 | 100% | 126.04 | 430 / 430 |
pancreas | 100% | 19134.03 | 328 / 328 | 100% | 117.61 | 178 / 178 |
prostate | 100% | 8317.20 | 245 / 245 | 100% | 245.48 | 502 / 502 |
stomach | 100% | 9079.82 | 359 / 359 | 100% | 146.01 | 286 / 286 |
breast | 100% | 8529.66 | 459 / 459 | 100% | 147.06 | 1117 / 1118 |
lung | 100% | 8990.53 | 578 / 578 | 100% | 128.19 | 1153 / 1155 |
uterus | 100% | 11181.43 | 170 / 170 | 100% | 120.30 | 458 / 459 |
skin | 100% | 11613.84 | 1808 / 1809 | 100% | 269.54 | 471 / 472 |
liver | 100% | 7189.32 | 225 / 226 | 100% | 113.38 | 406 / 406 |
thymus | 100% | 8020.73 | 653 / 653 | 100% | 122.61 | 602 / 605 |
intestine | 100% | 6976.02 | 966 / 966 | 99% | 170.51 | 524 / 527 |
esophagus | 100% | 6721.00 | 1444 / 1445 | 99% | 104.87 | 182 / 183 |
kidney | 100% | 5429.69 | 89 / 89 | 99% | 109.18 | 894 / 901 |
bladder | 100% | 8980.24 | 21 / 21 | 99% | 129.14 | 497 / 504 |
adrenal gland | 100% | 9497.23 | 258 / 258 | 97% | 120.84 | 223 / 230 |
brain | 97% | 4147.50 | 2558 / 2642 | 100% | 99.22 | 705 / 705 |
adipose | 100% | 8039.12 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8847.17 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 208.17 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 170.21 | 29 / 29 |
spleen | 100% | 8434.24 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 99.01 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 58.48 | 1 / 1 |
muscle | 99% | 4161.13 | 794 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 8610.28 | 902 / 929 | 0% | 0 | 0 / 0 |
heart | 94% | 5250.03 | 808 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006402 | Biological process | mRNA catabolic process |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0010587 | Biological process | miRNA catabolic process |
GO_0010564 | Biological process | regulation of cell cycle process |
GO_0031047 | Biological process | regulatory ncRNA-mediated gene silencing |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0097433 | Cellular component | dense body |
GO_0031332 | Cellular component | RNAi effector complex |
GO_0005829 | Cellular component | cytosol |
GO_0042470 | Cellular component | melanosome |
GO_0005634 | Cellular component | nucleus |
GO_0004521 | Molecular function | RNA endonuclease activity |
GO_0004519 | Molecular function | endonuclease activity |
GO_0016894 | Molecular function | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters |
GO_0045296 | Molecular function | cadherin binding |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_1905172 | Molecular function | RISC complex binding |
GO_0004518 | Molecular function | nuclease activity |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SND1 |
Protein name | Staphylococcal nuclease domain-containing protein (EC 3.1.31.1) Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator) Staphylococcal nuclease and tudor domain containing 1 |
Synonyms | hCG_32326 TDRD11 |
Description | FUNCTION: Endonuclease that mediates miRNA decay of both protein-free and AGO2-loaded miRNAs . As part of its function in miRNA decay, regulates mRNAs involved in G1-to-S phase transition . Functions as a bridging factor between STAT6 and the basal transcription factor . Plays a role in PIM1 regulation of MYB activity . Functions as a transcriptional coactivator for STAT5 (By similarity). .; FUNCTION: (Microbial infection) Functions as a transcriptional coactivator for the Epstein-Barr virus nuclear antigen 2 (EBNA2). .; FUNCTION: (Microbial infection) Promotes SARS-CoV-2 RNA synthesis by binding to negative-sense RNA and the viral protein nsp9. . FUNCTION: Endonuclease that mediates miRNA decay of both protein-free and AGO2-loaded miRNAs. . |
Accessions | ENST00000486037.1 Q7KZF4 A0A140VK49 H7C597 ENST00000354725.8 |